| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |